Novo Nordisk partners with OpenAI on drug development
Danish global healthcare company Novo Nordisk has announced a significant strategic partnership with AI research and deployment company OpenAI. The agreement marks a major step in the pharmaceutical giant’s efforts to integrate advanced artificial intelligence across its global value chain. According to its announcement on April 14, the maker of popular medications such as Ozempic and Wegovy intends to apply…